Abstract
Sugar-sweetened beverages (SSBs) are a major source of added sugars in the diet. A robust body of evidence has linked habitual intake of SSBs with weight gain and a higher risk (compared with infrequent SSB consumption) of type 2 diabetes mellitus, cardiovascular diseases and some cancers, which makes these beverages a clear target for policy and regulatory actions. This Review provides an update on the evidence linking SSBs to obesity, cardiometabolic outcomes and related cancers, as well as methods to grade the strength of nutritional research. We discuss potential biological mechanisms by which constituent sugars can contribute to these outcomes. We also consider global trends in intake, alternative beverages (including artificially-sweetened beverages) and policy strategies targeting SSBs that have been implemented in different settings. Strong evidence from cohort studies on clinical outcomes and clinical trials assessing cardiometabolic risk factors supports an aetiological role of SSBs in relation to weight gain and cardiometabolic diseases. Many populations show high levels of SSB consumption and in low-income and middle-income countries, increased consumption patterns are associated with urbanization and economic growth. As such, more intensified policy efforts are needed to reduce intake of SSBs and the global burden of obesity and chronic diseases.
【초록키워드】 review, clinical trial, obesity, cardiovascular disease, outcome, Population, cohort study, Clinical outcome, Regulatory, outcomes, cancers, Research, mechanism, cardiometabolic, Evidence, sugar, economic growth, Support, Chronic diseases, higher risk, cardiometabolic diseases, cardiometabolic risk factor, effort, robust, provide, added, contribute, reduce, Strong, SSB, type 2 diabete, 【제목키워드】 obesity, Epidemics, chronic disease,